1. Variation in use of anti-SARS-CoV-2 monoclonal antibody therapies by social vulnerability and urbanicity Author(s): Kolbe, Allison, author Publication: Washington, DC : Office of the Assistant Secretary for Planning and Evaluation, Office of Science & Data Policy, December 2021 Subject(s): Antibodies, Monoclonal, Humanized -- therapeutic useCOVID-19 Drug TreatmentHealthcare DisparitiesSocial VulnerabilityUrban PopulationVulnerable PopulationsUnited States
